Managing Patients With Moderate Penetrance Genes

Dr. Susan Domchek discusses the increased understanding of moderate penetrance genes and the importance of managing patients with these genes on a case-by-case basis.

Related Content:

San Antonio Breast Cancer Symposium: Street TeamBreast Cancer

Valentina Boni, MD, PhD, on Breast Cancer Advances from 2022 ASCO

Nuancing the Benefit of Circulating Tumor DNA

Clinical Trial Data on Use of ctDNA Assays